---
title: 'Associate Director/ Director Customer Engagement, International at BridgeBio Pharma'
canonical: 'https://feeny.ai/job/associate-director-director-customer-engagement-international-bridgebio-pharma-r2e136fd40b5'
type: 'job'
last_seen: '2026-10-14'
---

# Associate Director/ Director Customer Engagement, International at BridgeBio Pharma

- **Company:** BridgeBio Pharma
- **Location:** Zug, Switzerland
- **Posted:** 2026-10-13
- **Last confirmed live:** 2026-10-14
- **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5260189007

## Job description

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on

In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.

Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

## What You’ll Do

You will report to the Senior Director Commercial Excellence, International and work closely with country teams, International commercial functions, IT, and Corporate Communications to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers. Your primary purpose will be to build and own the International omnichannel customer engagement strategy, including digital and social activities across International markets. This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in omnichannel and digital customer engagement with strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.

## Responsibilities

- Define and own the International omnichannel customer engagement strategy across HCPs and patients, designing customer journeys and defining channel mix, sequencing, and engagement across personal and digital touchpoints
- Partner with the Sales Force Effectiveness to embed omnichannel plans into CRM, field execution, and next best action, and advise country teams and customer-facing functions on effective use of engagement tools and content
- Own the International digital channel landscape, including disease-awareness websites, HCP portals, email and marketing automation, and paid and organic social media, setting the website strategy, content roadmap, and social media governance
- Set content operations standards, including modular content requirements and localization guardrails, and own the omnichannel requirements for the CRM and digital tech infrastructure in partnership with CommEx and IT
- Own the International omnichannel measurement plan, defining KPIs and generating actionable insights from campaign, channel, and CRM data, and champion innovative approaches to customer engagement, including AI and large language model applications, piloting new tools in a compliant and measurable way
- Direct and quality-check the delivery of pilot campaigns and ecosystem-build work against the channel plan and standards, and manage digital agencies and technology vendors supporting omnichannel delivery

Where You’ll Work

This is an office-based role in our Zug, Switzerland office, requiring in-office collaboration 2-3x per week, with additional travel of up to 20% across International markets to support country teams, congresses, and launch readiness

## Who You Are

- BA or BS in Business, Life Sciences, or a related field; MBA or other advanced degree/certification preferred
- 8-10+ years of experience in the Pharmaceutical/Biotech industry, including experience in omnichannel, digital, or customer engagement roles, supporting product launches (specialty or rare disease strongly preferred)
- Demonstrated experience designing and executing omnichannel customer engagement strategies across multiple markets
- Hands-on experience with digital channels and platforms, including websites, email and marketing automation, and social media, together with CRM
- Proven track record of change management and driving adoption of new channels, processes, and platforms
- Advanced analytical and strategic skills, with the ability to turn engagement and campaign data into clear decisions and recommendations; experience in a lean or growth-stage organization preferred
- Prior exposure to multiple geographies strongly preferred, with deep expertise in at least one region required; fluency in English required

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

- Market leading compensation
- Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community
- We provide career development through regular feedback, continuous education and professional development programs
- We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities.

As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

For BridgeBio Full-Time U.S Based Roles:

Financial & Rewards

- Market-leading compensation
- 401(k) with employer match
- Employee Stock Purchase Program (ESPP)
- Pre-tax commuter benefits (transit and parking)
- Referral bonus for hired candidates
- Subsidized lunch and parking on in-office days

Health & Well-Being

- 100% employer-paid medical, dental, and vision premiums for you and your dependents
- Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA)
- Fertility & family-forming benefits
- Expanded mental health support (therapy and coaching resources)
- Hybrid work model with flexibility
- Flexible, “take-what-you-need” paid time off and company-paid holidays
- Comprehensive paid medical and parental leave to care for yourself and your family

Skill Development & Career Paths:

- People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
- We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching
- We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities

By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice). Questions or requests: dataprivacy@bridgebio.com

## About BridgeBio Pharma

## Company Overview
- **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization.
- **Entity Type**: Public (Nasdaq: BBIO)
- **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA)
- **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016.
- **Founders**: Not publicly available from provided sources.

## Core Business
- **Primary industry**: Biotechnology / Genetic disease therapeutics
- **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners
- **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.”

## Products & Services
BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings:

- **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential.
- **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026).
- **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9).
- **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1).
- **BBP-812**: Investigational for Canavan Disease.
- **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers.
- **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology.
- **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more.

The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**.

## Market Standing
- **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number).
- **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years.
- **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research.
- **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted.

## Competitive Advantages
- **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction.
- **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale.
- **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech.
- **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions.

## Strategic Focus
- **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals.
- **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers.
- **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster.
- **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach.

## Why Work Here
- **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025.
- **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized.
- **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility.
- **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra.
- **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.”
- **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles.

## Sources
1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential
2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics
3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits
4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation
5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories

## Other roles at BridgeBio Pharma

- [Associate Director, HEOR & Market Access, EU West](https://feeny.ai/job/associate-director-heor-market-access-eu-west-bridgebio-pharma-france-6k1tdatpyfa7) — France
- [Executive Director/Vice President Global Media Relations, Executive Communications & Comm Ops](https://feeny.ai/job/executive-director-vice-president-global-media-relations-executive-8m4sdjpbpgt1) — Palo Alto
- [Associate Director/ Director, Sales Force Effectiveness, International](https://feeny.ai/job/associate-director-director-sales-force-effectiveness-international-bridgebio-cbd6wfzs86ss) — Zug, Switzerland
- [Senior Manager, Insights & Forecasting, International](https://feeny.ai/job/senior-manager-insights-forecasting-international-bridgebio-pharma-zug-11ax8v3ykxvd) — Zug, Switzerland
- [Director, Managed Markets - Regional - West](https://feeny.ai/job/director-managed-markets-regional-west-bridgebio-pharma-united-states-apfnzdx6eqgf) — United States
- [Director, Managed Markets - Regional - Central](https://feeny.ai/job/director-managed-markets-regional-central-bridgebio-pharma-united-states-dm447m7g3k3e) — United States
- [Director, Managed Markets—National Accounts](https://feeny.ai/job/director-managed-markets-national-accounts-bridgebio-pharma-united-states-nf18z7wph0mz) — United States
- [Senior Director, Market Access Strategy, International](https://feeny.ai/job/senior-director-market-access-strategy-international-bridgebio-pharma-zug-v4k5h0wh3b0c) — Zug, Switzerland
- [Senior MLR Specialist](https://feeny.ai/job/senior-mlr-specialist-bridgebio-pharma-united-states-f1tbcn8vc88t) — United States
- [Sr Director/Executive Director, Pharm Science Technical Lead](https://feeny.ai/job/sr-director-executive-director-pharm-science-technical-lead-bridgebio-pharma-x10e5rkhnna4) — San Francisco